Literature DB >> 15271836

National Institute for Clinical Excellence and its value judgments.

Michael D Rawlins1, Anthony J Culyer.   

Abstract

Keywords:  Health Care and Public Health; National Health Service; National Institute for Clinical Excellence (Great Britain)

Mesh：

Year:  2004        PMID： 15271836      PMCID： PMC487742          DOI： 10.1136/bmj.329.7459.224

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Sample size calculations in studies using the EuroQol 5D.

Authors:  M Roset; X Badia; N E Mayo
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

2.  Equity - some theory and its policy implications.

Authors:  A J Culyer
Journal:  J Med Ethics       Date:  2001-08       Impact factor: 2.903

3.  Economics and ethics in health care.

Authors:  A J Culyer
Journal:  J Med Ethics       Date:  2001-08       Impact factor: 2.903

Review 4.  A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research.

Authors:  R T Anderson; N K Aaronson; M Bullinger; W L McBee
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 5.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

Review 6.  Equity and equality in health and health care.

Authors:  A J Culyer; A Wagstaff
Journal:  J Health Econ       Date:  1993-12       Impact factor: 3.883

7.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Authors:  A Laupacis; D Feeny; A S Detsky; P X Tugwell
Journal:  CMAJ       Date:  1992-02-15       Impact factor: 8.262

8.  The rationing debate: Maximising the health of the whole community. The case for.

Authors:  A J Culyer
Journal:  BMJ       Date:  1997-03-01

9.  Need: the idea won't do--but we still need it.

Authors:  A J Culyer
Journal:  Soc Sci Med       Date:  1995-03       Impact factor: 4.634

10.  Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.

Authors:  J Brazier; N Jones; P Kind
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147
  10 in total
  186 in total

1.  Challenges for the National Institute for Clinical Excellence.

Authors:  Alan Maynard; Karen Bloor; Nick Freemantle
Journal:  BMJ       Date:  2004-07-24

2.  NICE and its value judgments: favourable appraisal amounts to compulsory purchase order.

Authors:  Jammi N Rao
Journal:  BMJ       Date:  2004-09-25

3.  NICE and its value judgments: option of safe "understudy" treatments should be available.

Authors:  Woody Caan
Journal:  BMJ       Date:  2004-09-25

4.  NICE and its value judgments: utilitarian values are inadequate.

Authors:  William House; David Peters
Journal:  BMJ       Date:  2004-09-25

5.  Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.

Authors:  Tania Stafinski; Devidas Menon; Caroline Davis; Christopher McCabe
Journal:  Clinicoecon Outcomes Res       Date:  2011-08-30

6.  Health care costs: how do we decide value? When do we decide? How do we particularize the decisions?

Authors:  Richard L Theriault
Journal:  Oncologist       Date:  2012-02-02

Review 7.  Crossing the fourth hurdle.

Authors:  Michael D Rawlins
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

8.  Pharmacoeconomics: NICE's approach to decision-making.

Authors:  Michael Rawlins; David Barnett; Andrew Stevens
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

9.  Utilities and QALYs in health economic evaluations: glossary and introduction.

Authors:  Gianni Virgili; Daniela Koleva; Livio Garattini; Rita Banzi; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-07-06       Impact factor: 3.397

10.  Use of economic evaluation in decision making: evidence and recommendations for improvement.

Authors:  Steven Simoens
Journal:  Drugs       Date:  2010-10-22       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.